The Brussels International Declaration on Lp(a) testing and management has been published in Atherosclerosis,1 as a clear roadmap for policymakers to implement practical, life-changing policies and systemic reforms focused on the importance of Lp(a) as an independent causal risk factor for cardiovascular (CV) disease.
